SI
ABBV icon

Stirlingshire Investments’s AbbVie ABBV Stock Holding History

Stirlingshire Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$241K Buy
956
+6
+0.6% +$1.29K 0.18% 186
2026
Q1 		$207K Sell
950
-776
-45% -$172K 0.18% 186
2025
Q4 		$394K Buy
+1,726
New +$393K 0.35% 75

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Stirlingshire Investments's ABBV Position: Q2 2026 in Review

Stirlingshire Investments increased its AbbVie (ABBV) stake by 0.63% in Q2 2026, buying an estimated $1.29K and bringing the position to 956 shares worth $241K. The position accounts for 0.18% of the portfolio, ranked #186.

Stirlingshire Investments first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. The position peaked at $394K in Q4 2025. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Stirlingshire Investments held 956 shares of AbbVie worth $241K as of Q2 2026.
  • Stirlingshire Investments bought 6 AbbVie shares in Q2 2026, an estimated $1.29K.
  • AbbVie made up 0.18% of Stirlingshire Investments's portfolio in Q2 2026, its #186 holding.
  • Stirlingshire Investments first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • Stirlingshire Investments's AbbVie position peaked at $394K in Q4 2025.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Stirlingshire Investments's 13F filing for Q2 2026, filed 31 Jul 2026.